Advertencia para usuarios de Ozempic: el efecto secundario que podría causar ceguera
La Administración de Alimentos y Medicamentos de Estados Unidos (FDA) anunció ayer (lunes) la adición de una advertencia a medicamentos populares para el tratamiento de la diabetes y la obesidad, entre ellos Ozempic, Wegovy y…
Valoración
The FDA has added a warning to popular diabetes and weight loss drugs, including Ozempic, Wegovy, and Mounjaro, over a rare but serious risk of vision loss. The condition, NAION, involves damage to the optic nerve from reduced blood supply and can lead to sudden blindness. Patients using these medications should be aware of this newly flagged side effect and consult their doctors if they experience vision changes.